Search For Lab Tests Here

The Direct LDL Test measures low-density lipoprotein (LDL) cholesterol directly, without requiring fasting or calculation from triglycerides. LDL is known as “bad cholesterol” because high levels contribute to plaque buildup, heart disease, and stroke risk. Doctors order this test for patients with diabetes, high triglycerides, or cardiovascular risk. Results provide accurate insight into lipid health, helping guide treatment, prevention, and heart disease management.

The Cardio IQ™ Direct LDL Test directly measures low-density lipoprotein cholesterol (LDL-C), the “bad cholesterol” linked to atherosclerosis and cardiovascular disease. Unlike calculated LDL, this test provides accurate results even with high triglycerides or non-fasting samples. Doctors use it to assess heart disease risk, guide therapy decisions, and monitor patients on lipid-lowering treatments to improve cardiovascular health outcomes.

 The CVD-3 High Cholesterol Testing panel is a thorough diagnostic tool aimed at evaluating cardiovascular health by examining a broad spectrum of lipid profiles, inflammatory markers, and other specific tests related to heart disease risk. This panel includes Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol. It's designed for a comprehensive assessment of cardiovascular risk factors, particularly for individuals at high risk or with existing cardiovascular conditions.

 The CVD-4 High Cholesterol Testing panel represents the most comprehensive assessment in the series of cardiovascular diagnostics. It is designed to provide an extensive evaluation of cardiovascular risk factors, including genetic predispositions, lipid profiles, inflammatory markers, and more. This panel includes the Cardio IQ™ ApoE Genotype, Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol.

The Advanced TRL Phenotyping & Therapy Readiness Panel provides a detailed evaluation of triglyceride-rich lipoproteins, atherogenic particle burden, inflammation, and metabolic readiness. By combining advanced lipid, NMR particle analysis, ApoB, ApoC-III, insulin, liver function, and OmegaCheck testing, this blood panel delivers deep insight into remnant-driven cardiovascular risk beyond standard cholesterol testing.

 The Lipid Panel with Direct LDL is a comprehensive blood test used to assess the levels of cholesterol and fats in the blood, which are critical indicators of heart health. This panel includes measurements of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, non-HDL cholesterol, triglycerides, and ratios that provide insights into cardiovascular risk.

The Remnant & Particle Burden Panel evaluates advanced lipid, particle, and inflammatory markers to uncover hidden cardiovascular risk. By combining a comprehensive lipid panel with ApoB, ApoC-III, Direct LDL, hs-CRP, and Lipoprotein (a), this blood test assesses atherogenic particle number, remnant burden, inherited risk, and vascular inflammation beyond standard cholesterol testing.

The Lipid Panel Test checks six key blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides, and the Chol/HDL ratio. This panel assesses risk for cardiovascular disease, heart attack, and stroke by evaluating cholesterol balance and fat levels in the blood. Doctors use lipid panel results for routine screening, treatment monitoring, and guiding lifestyle or medication adjustments.

Advanced cardiovascular panel measuring lipoprotein particle size and number, ApoB, Lipoprotein (a), hs-CRP, homocysteine, TSH, and a full lipid profile. Designed to refine atherosclerosis and coronary heart disease risk assessment beyond standard cholesterol testing, this panel supports deeper evaluation of arterial health, inflammation, and metabolic influences.

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

The Advanced Cholesterol Lab Panel is an extensive set of tests designed to provide a detailed profile of a person's cholesterol and lipoprotein levels. Unlike basic cholesterol tests, this advanced panel includes measurements of specific types of cholesterol particles, ratios, and additional markers that offer a deeper insight into cardiovascular health. The tests in this panel include Apolipoprotein B, Cholesterol/HDLC Ratio, Total Cholesterol, HDL Cholesterol, LDL Cholesterol, LDL/HDL Ratio, Non-HDL Cholesterol, Triglycerides, Lipoprotein (a), HDL Large, LDL Medium, LDL Particle Number, LDL Pattern, LDL Peak Size, and LDL Small.

The Atherosclerotic Risk Screening Panel evaluates key cardiovascular risk markers including cholesterol, blood sugar control, metabolic function, and inflammation. By combining a Lipid Panel, Hemoglobin A1c, Comprehensive Metabolic Panel, and hs-CRP, this comprehensive assessment helps identify factors linked to arterial plaque development and long-term heart health.